Loading...
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control.

PropertyValue
has minor subject area list Administration, Inhalation; Adolescent; Child; Child, Preschool; Female; Fluticasone; Humans; Male; Pharmacogenetics; Polymorphism, Genetic; Prospective Studies; Surveys and Questionnaires
information resource reference Stockmann C, Fassl B, Gaedigk R, Nkoy F, Uchida DA, Monson S, Reilly CA, Leeder JS, Yost GS, Ward RM. Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control. J Pediatr. 2013 Jun; 162(6):1222-7, 1227.e1-2.
label Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control.

Search Criteria
  • Pediatric
  • Pharmacogenetics